Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test
SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix
Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test
SEOUL, South Korea, June 13, 2023 /PRNewswire/ -- Gencurix
Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX
SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix
Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX
SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix
Gencurix announced Korean and Japanese cancer patients' 15-year follow-up prognostic test clinical results
SEOUL, South Korea, May 9, 2023 /PRNewswire/ -- Gencurix
Gencurix wins FDA EUA for COVID-19 Test Kit
SEOUL, South Korea, June 24, 2020 /PRNewswire/ -- A Korean molecular diagnostic
company, Gencurix, Inc., has announced that they have received U.S. Food and
Drug Administration (FDA)'s Emergency Use Authorization (EUA) for its GenePro
SARS-CoV-2 Test.
Gencurix Releasing New Coronavirus Diagnostic Kit in the EU
SEOUL, South Korea, March 20, 2020 /PRNewswire/ -- A new diagnostic kit for the COVID-19, developed by Gencurix (KONEX 229000), will be available soon in Europe. GenePro COVID-19 Detection Test, developed in accordance to the WHO (World Health Organization) guidance for 'Laboratory testing for 2...
